DNA Capital

Investor type

PE / VC

Founded

2013

AUM

-

Location

São Paulo, São Paulo, Brazil

Investment Ticket

$1-5 m

Investment Stage

Series B

Region of investment

North America South America
Investor profile last updated: 21 August, 2026

Profile

DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector. Our mission is to invest in and provide strategic value to the best companies and founding teams in healthcare. Our team is multidisciplinary, deeply rooted in healthcare and passionate about finding and helping the best companies to thrive.

Industry

Business Services (B2B) Fintech Healthcare Services Education Edtech Fashion/Beauty Financial Services Medical Devices Pharmaceuticals MedTech Life Sciences Infrastructure HealthTech

Contacts

Name
Title
Email
avatar
Luiz Felipe D Martins Costa Managing Partner
Managing Partner
l•••@•••
avatar
Christopher Hill Partner
Partner
c•••@•••
Upgrade to see contacts
avatar
27Ff6Q4jYAvSWmpV 27Ff6Q4jYAvSWmpV
27Ff6Q4jYAvSWmpV
avatar
27Ff6Q4jYAvSWmpV 27Ff6Q4jYAvSWmpV
27Ff6Q4jYAvSWmpV
avatar
27Ff6Q4jYAvSWmpV 27Ff6Q4jYAvSWmpV
27Ff6Q4jYAvSWmpV
Investment-team contacts for DNA Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about DNA Capital

DNA Capital is a venture capital and private equity firm. It backs companies at Series B, writing tickets of $1-5 m.
DNA Capital is located in São Paulo, São Paulo, Brazil.
DNA Capital was founded in 2013.
DNA Capital invests in companies and startups in Business Services (B2B), Fintech, Healthcare Services, Education, Edtech, Fashion/Beauty, Financial Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, Infrastructure, HealthTech.
DNA Capital invests in companies and startups in North America, South America.
DNA Capital invests in companies and startups at Series B.
DNA Capital usually invests $1-5 m on average.
DNA Capital can be reached through its website dnacapital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for DNA Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query DNA Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.